Generic User Fee 'Relief' For Small Firms Would Mean Bigger Bills For Large One
This article was originally published in The Pink Sheet Daily
Executive Summary
Talks between industry and FDA focus on size of the discount and how a small business would be defined.
You may also be interested in...
FDA Contradicts AAM's Generic Market Consolidation Argument
As the generic industry trade group warns shortages could emerge as number of manufacturers contracts, US FDA says many new firms gaining approvals and identifying facilities.
FDA Contradicts AAM's Generic Market Consolidation Argument
As the generic industry trade group warns shortages could emerge as number of manufacturers contracts, US FDA says many new firms gaining approvals and identifying facilities.
Generic Industry Consolidating But Still Mysterious
Nearly 2,000 ANDAs remain unclaimed as US FDA begins fee calculations for GDUFA II.